Procter & Gamble (PG) Pantene Launch Puts Its Pricey Valuation Back In Focus

Pantene parent Procter & Gamble (PG) is back in the spotlight after the hair care label introduced Cream to Mist, a leave-in spray co-created with certified trichologist and social media advocate Abbey Yung.

For context, Procter & Gamble shares last closed at US$144.91, with a 1-day share price return of 0.67%, while the 1-year total shareholder return is down 2.04%, hinting that recent product launches like Cream to Mist arrive during a phase of softer momentum. At the same time, the 5-year total shareholder return of 16.25% points to steadier long-run compounding.

Scan beyond Procter & Gamble and see how other consumer brands with strong fundamentals stack up using our hand picked list of solid balance sheet and fundamentals (25 results)

Recent returns hint at softer enthusiasm for Procter & Gamble rather than a collapse in fundamentals. The question now is whether today's share price lines up with the underlying cash generation or reflects cooler sentiment instead.

Most Popular Narrative: 35% Overvalued

On Simply Wall St, the most followed valuation narrative for Procter & Gamble pins fair value at $107.52. This sits well below the recent $144.91 close and frames the current share price as rich against that estimate.

From what we have seen it is also clear that the overall business is very stable and predictable, but its stability comes with a hefty price tag at today’s quote. The valuation work suggests that most of the quality is already reflected in the share price, so future returns rely heavily on investors continuing to pay up for that stability.

See why 34 investors see Procter & Gamble as 35% overvalued.

Result: Fair Value of $107.52 (OVERVALUED)

Still, stronger rival promotions or a shift in consumer preferences away from core categories could challenge Procter & Gamble and soften the overvaluation argument.

Find out about the key risks to this Procter & Gamble narrative.

Another View On Procter & Gamble’s Value

While the most followed narrative on Simply Wall St points to Procter & Gamble trading around 35% above a US$107.52 fair value estimate, the SWS DCF model paints a very different picture. On that approach, PG at US$144.91 is described as trading 26.4% below an estimated future cash flow value of US$196.96. This frames today’s level as undervalued instead of stretched and leaves investors asking which set of assumptions feels more realistic for a slow growing staple giant.

For a closer look at how those cash flow assumptions stack up against each other, use the Look into how the SWS DCF model arrives at its fair value..

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Procter & Gamble for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 31 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Mixed messages on Procter & Gamble's value and prospects can be hard to reconcile. Move quickly, review the data yourself, and weigh up the 4 key rewards and 2 important warning signs

Looking for more investment ideas beyond Procter & Gamble?

If Procter & Gamble has you thinking harder about value, do not stop at a single stock when the wider market is full of potential ideas.

• Target steadier portfolios by focusing on resilience and capital discipline through our 31 resilient stocks with low risk scores.
• Hunt for quality at a discount by scanning companies that pair solid fundamentals with attractive entry prices using the 31 high quality undervalued stocks.
• Build a cash focused plan by pinpointing income opportunities across markets with the 7 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com